Tyrikos-Ergas Theodore, Agiakloglou Sevasti, LaPorte Antonio J, Wang Wesley, Chan Chieh-Kai, Wells Clare E, Rakowski Christopher K, Hammond Rachel I, Qiu Jia, Raymond Jonathan D, Vieira Tiago, Limanto John, Feiglin Marc N, Blair Daniel J, Burke Martin D
Department of Chemistry, University of Illinois, Urbana, IL, 61820, USA.
Deerfield Discovery & Development LLC, a subsidiary of Deerfield Management Company, 345 Park Ave S, New York, NY, 10010, USA.
Angew Chem Int Ed Engl. 2025 Aug 11;64(33):e202509974. doi: 10.1002/anie.202509974. Epub 2025 Jun 30.
Small molecule solutions to many contemporary societal challenges await discovery, but the artisanal and manual process via which this class of chemical matter is typically accessed limits the discovery of new functions. Automated assembly of (N-methyl iminodiacetic acid) MIDA or (tetramethyl N-methyl iminodiacetic acid) TIDA boronate building blocks via iterative C─C bond formation, an approach we call "block chemistry", alternatively enables generalized and automated preparation of many different types of small molecules in a modular fashion. But in its current form, this engine cannot also leverage nitrogen atoms as iteration handles. Here, we disclose a new iteration-enabling group, CbzT (p-TIDA boronate-substituted carboxybenzyl), that reversibly attenuates the reactivity of nitrogen atoms and enables generalized catch-and-release purification. CbzT is leveraged to achieve the automated modular synthesis of Imatinib (Gleevec), an archetypical clinically approved kinase inhibitor, in which building blocks are iteratively linked by both N─C and C─C bonds. This work substantially expands the types of small molecules that can be iteratively assembled in an automated modular fashion. It also advances the concept of intentionally developing chemistry that machines can do.
许多当代社会挑战的小分子解决方案有待发现,但获取这类化学物质通常采用的手工和人工方法限制了新功能的发现。通过迭代C─C键形成自动组装(N-甲基亚氨基二乙酸)MIDA或(四甲基N-甲基亚氨基二乙酸)TIDA硼酸酯结构单元,我们称之为“模块化学”的方法,能够以模块化方式实现多种不同类型小分子的通用和自动化制备。但就其目前的形式而言,该方法还不能将氮原子用作迭代手柄。在此,我们公开了一种新的迭代基团CbzT(对-TIDA硼酸酯取代的羧苄基),它能可逆地减弱氮原子的反应性,并实现通用的捕获-释放纯化。利用CbzT实现了伊马替尼(格列卫)的自动模块化合成,伊马替尼是一种典型的临床批准的激酶抑制剂,其结构单元通过N─C和C─C键进行迭代连接。这项工作极大地扩展了能够以自动模块化方式进行迭代组装的小分子类型。它还推动了有意开发机器可执行化学的概念。